Indian Cisplatin Exporters: Complete Supplier Ranking with Market Share — 233 Manufacturers (2026) — TransData Nexus

Q: Who is the largest cisplatin supplier from India?

FRESENIUS KABI ONCOLOGY LIMITED is the largest cisplatin exporter from India with a 21.5% market share and export value of $2.8M.

Q: How many cisplatin suppliers are there in India?

There are 233 active cisplatin exporters in India, collectively shipping $12.8M worth of cisplatin across 1,701 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top cisplatin suppliers from India?

The top 5 cisplatin suppliers from India — FRESENIUS KABI ONCOLOGY LIMITED, VENUS REMEDIES LIMITED, INTAS PHARMACEUTICALS LIMITED, NV REMEDIES PRIVATE LIMITED, MYLAN LABORATORIES LIMITED — together control 61.9% of total cisplatin export value from India.

Suresh Sormare

Cisplatin

India Pharmaceutical Trade Intelligence

$12.8M233 Suppliers130 CountriesHS 30049047

ExportsIndia → TAIWAN12.4%India → HUNGARY10.7%

ImportsGERMANY → India$9.5K UNITED STATES → India$2.3K

#1 Supplier: FRESENIUS KABI

Cisplatin Suppliers from India (2026) — 233 Exporters, $12.8M Market | TransData Nexus | TransData Nexus

Who Exports Cisplatin from India — 233 Suppliers Behind a $12.8M Market

India's cisplatin export market is supplied by 233 active exporters who collectively shipped $12.8M across 1,701 shipments. FRESENIUS KABI ONCOLOGY LIMITED leads with a 21.5% market share, followed by VENUS REMEDIES LIMITED and INTAS PHARMACEUTICALS LIMITED. The top 5 suppliers together control 61.9% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Cisplatin Suppliers & Exporters — 233 manufacturers, $12.8M export market, top destinations and formulations — Cisplatin supplier data — 233 exporters · $12.8M market · 1,701 shipmentsTransData Nexus · Indian Customs Data

Top Cisplatin Exporters from India — Ranked by Export Value

FRESENIUS KABI ONCOLOGY LIMITED is the leading cisplatin exporter from India, holding a 21.5% share of the $12.8M market across 1,701 shipments from 233 exporters. The top 5 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, VENUS REMEDIES LIMITED, INTAS PHARMACEUTICALS LIMITED, NV REMEDIES PRIVATE LIMITED, MYLAN LABORATORIES LIMITED — collectively control 61.9% of total export value, indicating a moderately concentrated market. Individual shares are: FRESENIUS KABI ONCOLOGY LIMITED (21.5%), VENUS REMEDIES LIMITED (12.9%), INTAS PHARMACEUTICALS LIMITED (11.3%), NV REMEDIES PRIVATE LIMITED (10.1%), MYLAN LABORATORIES LIMITED (6.0%).

Top Cisplatin Exporters from India

Ranked by export value · 233 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Cisplatin Exporters from India — Ranked by Export Value. 233 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Cisplatin exporters

Certification and compliance status for top Cisplatin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Fresenius Kabi Oncology Limited	Warning Letter (December	Yes	Yes	Not verified	Received FDA warning letters in December 2017 for CGMP violations at Kalyani and
Venus Remedies Limited	Not Listed	Yes	Yes	Not verified	Secured EU GMP renewal from Infarmed, Portugal, in January 2025 for cephalospori
Gland Pharma Limited	Approved	Yes	Yes	Not verified	Manufacturing facilities approved by FDA, WHO, and EU authorities.
Intas Pharmaceuticals Limited	Approved	Yes	Yes	Not verified	Holds approvals from FDA, WHO, and EU GMP certifications.
Mylan Laboratories Limited	Approved	Yes	Yes	Not verified	Facilities approved by FDA, WHO, and EU authorities.
Naprod Life Sciences Private Limited	Not Listed	Yes	Yes	Not verified	Holds WHO and EU GMP certifications for oncology products.
United Biotech Private Limited	Not Listed	Yes	Yes	Not verified	Certified by WHO and EU GMP authorities for pharmaceutical manufacturing.
SP Accure Labs Private Limited	Not Listed	Yes	Yes	Not verified	Holds WHO and EU GMP certifications for pharmaceutical products.

TransData Nexus reviewed the regulatory standing of 8 leading Cisplatin exporters from India. 3 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Cisplatin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes to more than 40% of the country's bulk drug production. The city hosts numerous bulk drug manufacturers, including Vasudha Pharma Chem Ltd, which specializes in active pharmaceutical ingredients (APIs) and intermediates. The presence of esteemed research institutions like the National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad further strengthens the region's pharmaceutical capabilities. NIPER Hyderabad aims to be a principal source of professional manpower in the field, enhancing the Indian pharmaceutical industry's capacity to produce quality products at affordable prices.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Vadodara, in particular, is home to major pharmaceutical companies like Alembic Pharmaceuticals, which manufactures and markets a wide range of pharmaceutical products, including APIs and formulations. The region's robust infrastructure and skilled workforce make it a pivotal hub for pharmaceutical formulations in India.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Cisplatin exporters from India

October 21, 2025

M&A

Intas Pharmaceuticals Limited — Intas' Accord Plasma acquires Prothya Biosolutions

Accord Plasma, a subsidiary of Intas Pharmaceuticals, completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This acquisition adds Prothya’s European plasma fractionation facilities and collection network, including operations in Amsterdam, Brussels, and Hungary, to Accord’s global plasma manufacturing footprint, expanding production and access to plasma-derived medicines. - IMPACT: This acquisition enhances Intas Pharmaceuticals' manufacturing capabilities, potentially increasing their capacity for Cisplatin production and export.

Impact: This acquisition enhances Intas Pharmaceuticals' manufacturing capabilities, potentially increasing their capacity for Cisplatin production and export.

October 15, 2025

M&A

Mylan Laboratories Limited — Viatris acquires Aculys Pharma for CNS assets

Viatris Inc., the parent company of Mylan Laboratories Limited, acquired clinical-stage Aculys Pharma, Inc., obtaining exclusive development and commercialization rights in Japan for pitolisant and rights in Japan and select Asia-Pacific markets for Spydia (diazepam) nasal spray. - IMPACT: While this acquisition focuses on central nervous system assets, it may allow Mylan Laboratories to reallocate resources towards enhancing their oncology portfolio, including Cisplatin exports.

Common Questions — Cisplatin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which cisplatin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, FRESENIUS KABI ONCOLOGY LIMITED leads with 60 recorded shipments worth $2.8M. VENUS REMEDIES LIMITED (121 shipments) and INTAS PHARMACEUTICALS LIMITED (73 shipments) are also established high-volume exporters.

Q How many cisplatin manufacturers are there in India?

India has 233 active cisplatin exporters with a combined export market of $12.8M across 1,701 shipments to 130 countries. The top 5 suppliers hold 61.9% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for cisplatin from India?

Average FOB unit price: $4.29 per unit, ranging from $0.01 to $525.99. Average shipment value: $7.6K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cisplatin

Cisplatin

Who Exports Cisplatin from India — 233 Suppliers Behind a $12.8M Market

Top Cisplatin Exporters from India — Ranked by Export Value

Top Cisplatin Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Intas Pharmaceuticals Limited — Intas' Accord Plasma acquires Prothya Biosolutions

Mylan Laboratories Limited — Viatris acquires Aculys Pharma for CNS assets

Common Questions — Cisplatin Suppliers from India

Q Which cisplatin supplier from India is the most reliable for bulk orders?

Q How many cisplatin manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for cisplatin from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Mylan Laboratories Limited — Mylan acquires Famy Care's female health business

Analysis Methodology